{"url":"https://newsforagent.com/news/2026-10-30/aphranel-european-physicians-china-exchange","markdown_url":"https://newsforagent.com/news/2026-10-30/aphranel-european-physicians-china-exchange.md","title":"Aphranel Hosts European Physicians in China Clinical Exchange","headline":"Aphranel Brings European Doctors to China for Week-Long Injection Training Exchange","description":"Aphranel launched a week-long clinical exchange bringing European physicians to China, drawing on a network of more than 620 partner clinics and 700 certified doctors.","section":"Expansion","published_at":"2026-10-30T09:24:52+00:00","modified_at":"2026-10-30T09:24:52+00:00","author":"News Desk","key_takeaways":["Aphranel launched a week-long clinical exchange programme bringing European physicians to China under the banner 'Learning in China, Applying in Europe'.","The programme forms part of The Norns' Weave, a global academic initiative built on three pillars: Dialogue, Exchange and Convergence.","Aphranel reports more than 620 partner aesthetic clinics, over 700 certified physicians and more than 200,000 syringes used in China within about a year of launch."],"companies":[{"name":"Aphranel","is_primary":true,"profile_url":"https://akta.pro/company-profiles/003znds/aphranel","website":"https://www.aphranel.com"}],"source":{"publisher":"PR Newswire","title":"aphranel® Hosts European Physicians in China for Clinical Exchange","url":"https://www.prnewswire.com/news-releases/aphranel-hosts-european-physicians-in-china-for-clinical-exchange-302924631.html"},"other_sources":[],"tags":["Expansion","Aphranel"],"body_markdown":"[Aphranel](https://akta.pro/company-profiles/003znds/aphranel), the regenerative aesthetics brand of MOYOM Biotech, has launched a week-long clinical exchange programme bringing European physicians to China for clinical observation and discussion, [PR Newswire](https://www.prnewswire.com/news-releases/aphranel-hosts-european-physicians-in-china-for-clinical-exchange-302924631.html) reported on October 30, 2026. The programme runs under the theme \"Learning in China, Applying in Europe\" and forms part of The Norns' Weave, a global academic initiative.\n\n## Inside the Aphranel Clinical Exchange\n\nDr. Tiago Guimarães, accompanied by the Aphranel European Medical and Sales Team, visited China for a multi-city clinical immersion programme with Aphranel-certified Chinese physicians. The delegation visited Yestar Medical Aesthetic Hospital and Huamei Zixin Medical Aesthetic Hospital in Guangzhou; Shenzhen Fanyan Aesthetics and Shenzhen Boai Shuguang Hospital in Shenzhen; REAL Medical Aesthetics in Shanghai; and Estee Ryan and JollyHue in Hangzhou.\n\nThrough facial aesthetic assessments, clinical case discussions and injection demonstrations, participating physicians exchanged practical insights into individualised treatment planning and CaHA-based facial biostructuring. Discussions covered differences in ethnic background, facial anatomy and aesthetic preferences across regions, and examined use of the biostructurer at different anatomical depths, including placement onto the periosteum for deep structural support and injection into more superficial layers to improve soft-tissue quality.\n\nAphranel draws on more than 12 years of research and development and expanded internationally after NMPA Class III medical device approval for its MagiCCrystal CaHA filler in China in 2025 and EU MDR certification in 2026. The Norns' Weave has also included exchanges with medical communities in the Middle East, including at the Saudi Arabian Aesthetic Medicine Scientific Conference in Riyadh and a subsequent visit by regional medical professionals to MOYOM Biotech's Shanghai headquarters.\n\n## Aphranel's Clinic and Physician Network\n\nAccording to akta.pro [company records](https://akta.pro/company-data), Aphranel announced in May 2026 an international expansion into Europe, the Middle East, Latin America and Southeast Asia, signing collaboration agreements with medical institutions across those regions. The same records list collaboration agreements with European, Middle Eastern and Asia-Pacific medical institutions covering physician exchange programmes, clinical collaboration and academic partnerships through The Norns initiative. Aphranel is a China-origin regenerative medical aesthetics brand under Shanghai Moyang Biotechnology that develops and sells CaHA microsphere injectable fillers and skinboosters to certified physicians and medical aesthetics clinics, according to its company profile.\n\n## Earlier Aphranel Milestones\n\nAphranel's MagiCCrystal CaHA Filler achieved European Union Medical Device Regulation certification on May 18, 2026, PR Newswire reported, making it among the first regenerative CaHA injectable fillers from the Asia-Pacific region to obtain direct MDR certification under the Class III pathway. In May 2026, Aphranel hosted its \"Twin Peaks Lecture\" and runway show at the Shanghai World Expo Museum under the Roma exhibition's dome, PR Newswire APAC reported. On October 9, 2026, Aphranel partnered with the 2026 MXGP Shanghai event to showcase its facial aesthetics, PR Newswire reported.\n\n## Aphranel's Planned European Exchanges\n\nMOYOM Biotech plans to extend The Norns' Weave through further European academic exchanges, Expert-to-Expert collaborations and continued development of clinical evidence, according to the report.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}